WallStreetZenWallStreetZen

NASDAQ: MCHX
Marchex Inc Stock

$1.39+0.05 (+3.73%)
Updated Mar 27, 2024
MCHX Price
$1.39
Fair Value Price
N/A
Market Cap
$60.21M
52 Week Low
$1.11
52 Week High
$2.20
P/E
-4.79x
P/B
1.62x
P/S
1.25x
PEG
N/A
Dividend Yield
N/A
Revenue
$49.81M
Earnings
-$12.34M
Gross Margin
56.7%
Operating Margin
-24.18%
Profit Margin
-24.8%
Debt to Equity
0.32
Operating Cash Flow
-$7M
Beta
1.1
Next Earnings
May 2, 2024
Ex-Dividend
N/A
Next Dividend
N/A

MCHX Overview

Marchex, Inc. operates as an analytics and solutions company that helps businesses connect, drive, measure, and convert callers into customers in the United States and Canada. Its products include Marchex Call Analytics, an analytics platform for enterprises, which depend on inbound phone calls to drive sales, appointments, and reservations; Marchex Call Analytics, Conversation Edition that enable actionable insights for enterprise, mid-sized, and small businesses; Text Analytics and Communications, a solution for intelligent mobile messaging, which enables sales, marketing, and operations teams in businesses to engage in two-way communications with field staff, prospects, and customers through text/SMS messages; Call Monitoring for call recording; and Marchex Marketing Edge, an analytics solution for marketers in enterprise, mid-sized and small businesses that depend on inbound phone calls to drive sales, appointments and reservations. The company's Marchex Sales Engagement products comprise Marchex Engage, which combines Marchex artificial intelligence and machine learning with call monitoring and scoring services; Marchex Spotlight, a product for corporate and regional managers; Marchex Engage for Automotive; and Marchex Platform Services that allows businesses to add Marchex conversation intelligence to their existing workflows and enabling them to decode what happens in their conversations with customers. Marchex, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MCHX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MCHX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MCHX is good value based on its book value relative to its share price (1.62x), compared to the US Advertising Agencies industry average (3.41x)
P/B vs Industry Valuation
MCHX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more MCHX due diligence checks available for Premium users.

Be the first to know about important MCHX news, forecast changes, insider trades & much more!

MCHX News

Valuation

MCHX fair value

Fair Value of MCHX stock based on Discounted Cash Flow (DCF)
Price
$1.39
Fair Value
$0.02
Overvalued by
8,200.02%
MCHX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

MCHX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-4.79x
Industry
28.28x
Market
44.45x

MCHX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.62x
Industry
3.41x
MCHX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MCHX's financial health

Profit margin

Revenue
$12.8M
Net Income
-$1.5M
Profit Margin
-12.1%
MCHX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
MCHX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$49.1M
Liabilities
$11.8M
Debt to equity
0.32
MCHX's short-term assets ($23.96M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MCHX's short-term assets ($23.96M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MCHX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MCHX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$378.0k
Investing
$64.0k
Financing
-$91.0k
MCHX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

MCHX vs Advertising Agency Stocks

TickerMarket Cap1d %P/EP/B
MCHX$60.21M+3.73%-4.79x1.62x
STCN$59.71M-1.55%9.57x0.77x
INUV$50.95M+9.91%-4.58x3.00x
WIMI$73.88M-5.33%-1.66x0.50x
FLNT$40.94M+3.92%-0.32x1.15x

Marchex Stock FAQ

What is Marchex's quote symbol?

(NASDAQ: MCHX) Marchex trades on the NASDAQ under the ticker symbol MCHX. Marchex stock quotes can also be displayed as NASDAQ: MCHX.

If you're new to stock investing, here's how to buy Marchex stock.

What is the 52 week high and low for Marchex (NASDAQ: MCHX)?

(NASDAQ: MCHX) Marchex's 52-week high was $2.20, and its 52-week low was $1.11. It is currently -36.82% from its 52-week high and 25.23% from its 52-week low.

How much is Marchex stock worth today?

(NASDAQ: MCHX) Marchex currently has 43,316,764 outstanding shares. With Marchex stock trading at $1.39 per share, the total value of Marchex stock (market capitalization) is $60.21M.

Marchex stock was originally listed at a price of $8.88 in Mar 31, 2004. If you had invested in Marchex stock at $8.88, your return over the last 19 years would have been -84.35%, for an annualized return of -9.3% (not including any dividends or dividend reinvestments).

How much is Marchex's stock price per share?

(NASDAQ: MCHX) Marchex stock price per share is $1.39 today (as of Mar 27, 2024).

What is Marchex's Market Cap?

(NASDAQ: MCHX) Marchex's market cap is $60.21M, as of Mar 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Marchex's market cap is calculated by multiplying MCHX's current stock price of $1.39 by MCHX's total outstanding shares of 43,316,764.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.